Amylyx Pharmaceuticals
Develops treatments for neurodegenerative diseases and endocrine conditions.
Company facts
- Founded
- 2013
- Employees
- 205
- Headquarters
- United States
- Type
- Public
- Listed
- NASDAQ: AMLX
- Subsidiaries
- Amylyx Pharmaceuticals Canada Inc., Amylyx Pharmaceuticals Japan K.K., Amylyx Pharmaceuticals EMEA B.V., Amylyx Pharmaceuticals UK Limited